CCRA Introduction to Certified Clinical Research Associate 5 — Questions and Answers
Question 1: Which of the following is a key difference between a CRA (Clinical Research Associate) and a CRC (Clinical Research Coordinator)?
- A CRA is typically employed by the sponsor or CRO and monitors sites; a CRC works at the investigator site and supports trial conduct (Correct answer)
- A CRA works at the clinical site; a CRC works for the regulatory agency
- A CRA approves the protocol; a CRC writes the informed consent form
- A CRA and a CRC perform identical functions in clinical research
Correct answer: A CRA is typically employed by the sponsor or CRO and monitors sites; a CRC works at the investigator site and supports trial conduct
CRAs are sponsor or CRO employees who monitor site compliance, while CRCs are site staff who assist investigators in day-to-day trial operations.
Question 2: What is the purpose of a Pre-Study Site Qualification Visit (SQV)?
- To evaluate whether the site and investigator have the capabilities, resources, and patient population to conduct the trial (Correct answer)
- To deliver investigational product to the site for the first time
- To collect final data and close out the study at the site
- To train site staff on the protocol after IRB approval
Correct answer: To evaluate whether the site and investigator have the capabilities, resources, and patient population to conduct the trial
An SQV assesses the site's facilities, staff qualifications, patient access, and overall feasibility before committing to site selection.
Question 3: According to ICH E6(R2), what is meant by 'essential documents'?
- Documents that individually and collectively permit evaluation of the conduct of a trial and the quality of the data produced (Correct answer)
- Only the signed informed consent forms from all enrolled subjects
- The sponsor's internal SOPs for clinical monitoring
- CRFs submitted to the FDA for regulatory review
Correct answer: Documents that individually and collectively permit evaluation of the conduct of a trial and the quality of the data produced
Essential documents are those that individually and collectively allow evaluation of the trial's conduct and data quality, and they form the Trial Master File.
Question 4: A sponsor is planning a multi-site trial across five countries. Which regulatory body's guidelines provide the internationally accepted standard for GCP that covers study design, conduct, performance, monitoring, and reporting?
- ICH (International Council for Harmonisation) through Guideline E6 (Correct answer)
- WHO (World Health Organization) through its Model List of Essential Medicines
- ISO (International Organization for Standardization) through ISO 14155
- CIOMS (Council for International Organizations of Medical Sciences)
Correct answer: ICH (International Council for Harmonisation) through Guideline E6
ICH E6 (Good Clinical Practice) is the internationally harmonized standard for the design, conduct, performance, monitoring, auditing, recording, analysis, and reporting of clinical trials.
Question 5: What action should a CRA take if a site refuses to correct a major protocol deviation identified during a monitoring visit?
- Escalate the issue to the sponsor's management and document the refusal in the monitoring report (Correct answer)
- Accept the site's position and close out the visit without further action
- Contact the FDA directly to report the site without notifying the sponsor
- Personally correct the deviation by altering the site's records
Correct answer: Escalate the issue to the sponsor's management and document the refusal in the monitoring report
When a site refuses corrective action, the CRA must document the refusal and escalate to sponsor management, who may involve regulatory authorities or terminate the site.
Question 6: The Declaration of Helsinki, as it relates to clinical research, emphasizes that:
- The well-being of individual research subjects must take precedence over the interests of science and society (Correct answer)
- Subjects may be enrolled without consent if the research has societal benefit
- Placebo-controlled trials are always unethical when existing treatment is available
- Investigators are not required to disclose conflicts of interest
Correct answer: The well-being of individual research subjects must take precedence over the interests of science and society
The Declaration of Helsinki places the health and rights of individual subjects above scientific and societal interests, forming an ethical cornerstone of clinical research.
Question 7: What is the function of a Study Coordinator Certification (e.g., CCRC from ACRP) compared to the CCRA certification?
- CCRC certifies site-level coordinators supporting investigators, while CCRA certifies sponsor/CRO monitors overseeing site compliance (Correct answer)
- Both certifications are identical and interchangeable in clinical research roles
- CCRA certifies site coordinators; CCRC certifies sponsor monitors
- CCRC is only relevant for oncology trials; CCRA applies to all therapeutic areas
Correct answer: CCRC certifies site-level coordinators supporting investigators, while CCRA certifies sponsor/CRO monitors overseeing site compliance
CCRC (Certified Clinical Research Coordinator) is for site staff supporting investigators, whereas CCRA is for clinical monitors employed by sponsors or CROs.
CCRA Introduction to Certified Clinical Research Associate 5
Which of the following is a key difference between a CRA (Clinical Research Associate) and a CRC (Clinical Research Coordinator)?